Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.

Carine A HalabySarah P YoungStephanie AustinEla StefanescuDeeksha BaliLani K ClintonBrian SmithSurekha PendyalJariya UpadiaGary R SchoolerAlisha M MavisPriya S Kishnani

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)

Liver fibrosis can occur at an early age, and may explain the decrease in aminotransferases and Glc4 with age. Our data outlines the need for systematic follow-up and specific biochemical and radiological tools to monitor the silent course of the liver disease process.

Keyphrases

liver fibrosis
type iii
electronic health record
big data
machine learning
artificial intelligence